Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sergeenko, Artem
NCT05544916: A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections	Completed	3	260	RoW	XC221, Placebo	Valenta Pharm JSC	Influenza, Respiratory Viral Infection	02/23	05/23
MMH-407-009, NCT06263881: Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia	Recruiting	3	370	RoW	Raphamin, MMH-407, Placebo	Materia Medica Holding	Community-acquired Pneumonia, Pneumonia	12/26	12/26
NCT05364671: Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients	Active, not recruiting	3	813	RoW	Raphamin, Placebo	Materia Medica Holding	Coronavirus Disease 2019 (COVID-19)	12/24	12/24
Goncharov, Oleg V
NCT05586789: A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia and Adjustment Disorders	Completed	3	220	RoW	Ranquilon, GB-115, 6-phenylhexanoyl)glycyl-L-tryptophan amide, Placebo	Valenta Pharm JSC	Anxiety, Neurasthenia, Adjustment Disorders	11/22	01/23